At ISC, the Fight Against COVID-19 Took the Stage – and Yes, Fugaku Was There

By Oliver Peckham

June 23, 2020

With over nine million infected and nearly half a million dead, the COVID-19 pandemic has seized the world’s attention for several months. It has also dominated the supercomputing sector, with COVID-related research receiving major allocations on nearly every research supercomputer in the world (and many industrial supercomputers). It’s not surprising, then, that at ISC 2020, the virtual conference opened, revealed the new Top500 list – and then got straight to COVID-19.

In the focus session, three speakers addressed how HPC is fighting back against the coronavirus: Satoshi Matsuoka of RIKEN, which just nabbed the top spot in the Top500 with its Fugaku system; Peter Coveney of the Centre of Excellence in Computational Biomedicine, which is working to make HPC and machine learning actionable in a rapid drug development workflow; and Rick Stevens of Argonne National Laboratory, where researchers are working with the COVID-19 HPC Consortium to comb through billions of molecules.

Satoshi Matsuoka highlights Fugaku’s role in COVID-19 research

Satoshi Matsuoka

Fugaku, the most powerful supercomputer in the world, is in business early thanks to COVID-19. The system – situated at Riken in Japan – was scheduled to launch in 2021. When the pandemic struck, plans changed. “It was decided by [Japan’s] Ministry of Education, Culture, Sports, Science and Technology that we will utilize [not only supercomputers that are already available] but also [deploy Fugaku early], almost a year ahead of schedule, to combat COVID-19,” explained Matsuoka, director of the Riken Center for Computational Science (R-CCS).

The Fugaku supercomputer

Fugaku’s showstopping 415 Linpack petaflops are close to triple the performance of the runner-up, Oak Ridge’s newly dethroned Summit system. At 158,976 nodes, Fugaku is the largest system ever created in terms of nodes, footprint and power consumption. The software, Matsuoka said, is “quite standard,” allowing for broad usability without much Fugaku-specific tweaking.

“They’re largely divided into two areas,” Matsuoka said of Fugaku’s COVID-19 workloads. “One is medical-pharma – so trying to see how the virus behaves, what are the effective drugs, especially how we can repurpose existing drugs and so forth and also how a vaccine is made. So these are molecular-level investigations of the virus and its countermeasures. The other is more macroscopic – so we’re trying to see how these viruses are transmitted and what are the mitigation measures and how it will impact society.”

Matsuoka highlighted several of the COVID-19 projects taking advantage of Fugaku’s early arrival. One Riken researcher, for instance, is studying conformational changes of the spike protein using a highly scalable molecular dynamics code. Another researcher is using fragment molecular orbital calculations to investigate the energy levels of the spike protein, scaling across hundreds of thousands of Fugaku’s CPUs. “On [Fugaku’s predecessor] the K computer,” Matsuoka said, “this calculation would have taken days, weeks, multiple weeks – on Fugaku, … they have been able to do this in just three hours.”

Other researchers are using Fugaku to run socially oriented simulations, such as simulating droplets in indoor spaces like trains or simulating the spread effects of using face masks or contact tracing applications, Matsuoka said – and, of course, there are more to come. “So if you have any good ideas,” he said, “go to the website and you can apply.” 

A Riken-led simulation of virus droplets in train cabins. Image courtesy of Satoshi Matsuoka.

Peter Coveney describes a new, HPC- and AI-driven model for drug development

Peter Coveney

Coveney, the second speaker, runs the Centre of Excellence in Computational Biomedicine (CompBioMed), an initiative funded by the European Union that is currently redirecting its research efforts and computational research to the study of and drug development for COVID-19. Coveney (who also teaches at University College London) stressed the need to “invert the model [of drug development] as it currently exists” using advanced IT.

“The opportunities there are enormous,” Coveney said. “What we’re really trying to do is transform the approach to biomedicine, to be able to move it from a highly empirical approach … to putting a priority on the predictions that come out of computers.”

But to do that, he said, the computational results had to be actionably accurate – and perhaps even more difficult, they had to be quickly produced. Molecular screening, however – the crux of computational drug design, whereby compounds are fitted to targets on the virus’ proteins – is labor-intensive, time-consuming and expensive ($1 to $10 a compound, with billions of compounds to screen for COVID-19).

Coveney outlined how CompBioMed worked with over 40 partners around the world to streamline the computational drug design pipeline. CompBioMed gained access to a wide range of supercomputers, from SuperMUC-NG (the most powerful supercomputer in the EU) to Piz Daint, Archer, Summit, Frontera, Theta and more. The researchers used a piece of middleware called Radical Cybertools to run workflows across a large number of nodes on multiple machines.

With computing power in hand, CompBioMed focused on how to ensure “validation, verification and uncertainty quantification” (or “VVUQ”) in the pipeline. “This is designed in general to raise confidence in HPC simulation,” Coveney said.

To effectively leverage the computing power and ensure “VVUQ,” CompBioMed combined machine learning with molecular dynamics. Machine learning was used first to whittle down the near-infinite list of candidate molecules. “We have to do searches in a hurry,” Coveney said. “We want to use computationally very fast methods that are also cheap … to search huge libraries of molecules, to explore chemical space, to predict new molecules and so on.” 

The ensemble molecular dynamics process. Image courtesy of Peter Coveney.

Then, with the list whittled down, CompBioMed used molecular dynamics simulations – 20 to 30 of them at a time. As Coveney explained, a single molecular dynamics simulation could have a large number of errors. “But if you run many of them concurrently … we can run those on very large supercomputers all at the same time,” Coveney said. “Then we can make reliable predictions that get fed back to another stage of the machine learning.”

The best candidate compounds from this process are then submitted to medical research labs for further testing. “We are already discovering many tens to hundreds of potential compounds that can be investigated by our experimental colleagues,” Coveney said. “And indeed, that’s happening already.”

“We’re trying to change the way medicine is actually understood and applied,” Coveney concluded. “We want to make the subject more amenable to scientific investigation, that it should revolve around theory, modeling and simulation in addition to experimental research.”

Rick Stevens dives into the COVID-19 HPC Consortium and machine learning-enabled research

Rick Stevens

Finally, Stevens took the virtual stage. Stevens – associate laboratory director at Argonne National Laboratory – has been working closely with the COVID-19 HPC Consortium, a public-private effort to pool supercomputing resources for COVID-19 research. Currently, the effort has over 40 members, comprising some 483 petaflops of resources, 50,000 GPUs, 136,000 nodes and five million CPU cores. 

As Stevens explained, the projects being tackled by the consortium fall into three broad categories: first, basic science, including things like analyzing the virus’ structure, protein functions and virus evolution; second, therapeutics (“the largest group”), aiming to discovery drug targets on the virus, design drugs and discover repurposable drugs; and finally, patient care – “things more related to optimizing the healthcare system or epidemiology.”

Stevens outlined some of the key work, especially where it intersected with Argonne. “If you’re gonna work on this problem, you need to understand the enemy,” Stevens said, describing how Argonne has used its Advanced Photon Source (APS) to identify new structures of COVID-19, which in turn produce new drug targets for simulations to examine. 

Like Coveney, Stevens highlighted the intersections of AI and supercomputing as viable pathways for processing massive amounts of compounds in a relatively short time frame. For instance, he said, researchers were using AI to reconcile models of proteins from various sources to produce even more accurate models. In the spring, Argonne also began assembling a large database – around 60 TB – containing descriptors, images and more for over four billion compounds, with the aim of producing massive datasets for machine learning applications.

“One of the strategies that we have is to use a combination of high-throughput virtual docking … to generate scores – generate them on thousands or millions of data points,” Stevens said, “but then use that data to train machine learning models and do inference on a much larger scale.” As in Coveney’s research, the most promising hits are then sent for wet lab screening. 

Argonne’s pipeline for COVID-19 drug discovery. Image courtesy of Rick Stevens.

Stevens also discussed the use of machine learning to understand the “trajectories” of molecular dynamics simulations and the use of reinforcement learning to essentially build drug molecules from the ground up, adding to them iteratively to improve the docking score.

“One of the overall challenges here, of course, is that there’s over 10⁶⁰ possible drugs,” Steven said, “and you can only test at the end of the day, in humans, a small fraction of these.” But now, with AI and supercomputing converging to create a new model of rapid drug design, that might be enough.

Subscribe to HPCwire's Weekly Update!

Be the most informed person in the room! Stay ahead of the tech trends with industry updates delivered to you every week!

Q&A with Nvidia’s Chief of DGX Systems on the DGX-GB200 Rack-scale System

March 27, 2024

Pictures of Nvidia's new flagship mega-server, the DGX GB200, on the GTC show floor got favorable reactions on social media for the sheer amount of computing power it brings to artificial intelligence.  Nvidia's DGX Read more…

Call for Participation in Workshop on Potential NSF CISE Quantum Initiative

March 26, 2024

Editor’s Note: Next month there will be a workshop to discuss what a quantum initiative led by NSF’s Computer, Information Science and Engineering (CISE) directorate could entail. The details are posted below in a Ca Read more…

Waseda U. Researchers Reports New Quantum Algorithm for Speeding Optimization

March 25, 2024

Optimization problems cover a wide range of applications and are often cited as good candidates for quantum computing. However, the execution time for constrained combinatorial optimization applications on quantum device Read more…

NVLink: Faster Interconnects and Switches to Help Relieve Data Bottlenecks

March 25, 2024

Nvidia’s new Blackwell architecture may have stolen the show this week at the GPU Technology Conference in San Jose, California. But an emerging bottleneck at the network layer threatens to make bigger and brawnier pro Read more…

Who is David Blackwell?

March 22, 2024

During GTC24, co-founder and president of NVIDIA Jensen Huang unveiled the Blackwell GPU. This GPU itself is heavily optimized for AI work, boasting 192GB of HBM3E memory as well as the the ability to train 1 trillion pa Read more…

Nvidia Appoints Andy Grant as EMEA Director of Supercomputing, Higher Education, and AI

March 22, 2024

Nvidia recently appointed Andy Grant as Director, Supercomputing, Higher Education, and AI for Europe, the Middle East, and Africa (EMEA). With over 25 years of high-performance computing (HPC) experience, Grant brings a Read more…

Q&A with Nvidia’s Chief of DGX Systems on the DGX-GB200 Rack-scale System

March 27, 2024

Pictures of Nvidia's new flagship mega-server, the DGX GB200, on the GTC show floor got favorable reactions on social media for the sheer amount of computing po Read more…

NVLink: Faster Interconnects and Switches to Help Relieve Data Bottlenecks

March 25, 2024

Nvidia’s new Blackwell architecture may have stolen the show this week at the GPU Technology Conference in San Jose, California. But an emerging bottleneck at Read more…

Who is David Blackwell?

March 22, 2024

During GTC24, co-founder and president of NVIDIA Jensen Huang unveiled the Blackwell GPU. This GPU itself is heavily optimized for AI work, boasting 192GB of HB Read more…

Nvidia Looks to Accelerate GenAI Adoption with NIM

March 19, 2024

Today at the GPU Technology Conference, Nvidia launched a new offering aimed at helping customers quickly deploy their generative AI applications in a secure, s Read more…

The Generative AI Future Is Now, Nvidia’s Huang Says

March 19, 2024

We are in the early days of a transformative shift in how business gets done thanks to the advent of generative AI, according to Nvidia CEO and cofounder Jensen Read more…

Nvidia’s New Blackwell GPU Can Train AI Models with Trillions of Parameters

March 18, 2024

Nvidia's latest and fastest GPU, codenamed Blackwell, is here and will underpin the company's AI plans this year. The chip offers performance improvements from Read more…

Nvidia Showcases Quantum Cloud, Expanding Quantum Portfolio at GTC24

March 18, 2024

Nvidia’s barrage of quantum news at GTC24 this week includes new products, signature collaborations, and a new Nvidia Quantum Cloud for quantum developers. Wh Read more…

Houston We Have a Solution: Addressing the HPC and Tech Talent Gap

March 15, 2024

Generations of Houstonian teachers, counselors, and parents have either worked in the aerospace industry or know people who do - the prospect of entering the fi Read more…

Alibaba Shuts Down its Quantum Computing Effort

November 30, 2023

In case you missed it, China’s e-commerce giant Alibaba has shut down its quantum computing research effort. It’s not entirely clear what drove the change. Read more…

Nvidia H100: Are 550,000 GPUs Enough for This Year?

August 17, 2023

The GPU Squeeze continues to place a premium on Nvidia H100 GPUs. In a recent Financial Times article, Nvidia reports that it expects to ship 550,000 of its lat Read more…

Shutterstock 1285747942

AMD’s Horsepower-packed MI300X GPU Beats Nvidia’s Upcoming H200

December 7, 2023

AMD and Nvidia are locked in an AI performance battle – much like the gaming GPU performance clash the companies have waged for decades. AMD has claimed it Read more…

DoD Takes a Long View of Quantum Computing

December 19, 2023

Given the large sums tied to expensive weapon systems – think $100-million-plus per F-35 fighter – it’s easy to forget the U.S. Department of Defense is a Read more…

Synopsys Eats Ansys: Does HPC Get Indigestion?

February 8, 2024

Recently, it was announced that Synopsys is buying HPC tool developer Ansys. Started in Pittsburgh, Pa., in 1970 as Swanson Analysis Systems, Inc. (SASI) by John Swanson (and eventually renamed), Ansys serves the CAE (Computer Aided Engineering)/multiphysics engineering simulation market. Read more…

Choosing the Right GPU for LLM Inference and Training

December 11, 2023

Accelerating the training and inference processes of deep learning models is crucial for unleashing their true potential and NVIDIA GPUs have emerged as a game- Read more…

Intel’s Server and PC Chip Development Will Blur After 2025

January 15, 2024

Intel's dealing with much more than chip rivals breathing down its neck; it is simultaneously integrating a bevy of new technologies such as chiplets, artificia Read more…

Baidu Exits Quantum, Closely Following Alibaba’s Earlier Move

January 5, 2024

Reuters reported this week that Baidu, China’s giant e-commerce and services provider, is exiting the quantum computing development arena. Reuters reported � Read more…

Leading Solution Providers

Contributors

Comparing NVIDIA A100 and NVIDIA L40S: Which GPU is Ideal for AI and Graphics-Intensive Workloads?

October 30, 2023

With long lead times for the NVIDIA H100 and A100 GPUs, many organizations are looking at the new NVIDIA L40S GPU, which it’s a new GPU optimized for AI and g Read more…

Shutterstock 1179408610

Google Addresses the Mysteries of Its Hypercomputer 

December 28, 2023

When Google launched its Hypercomputer earlier this month (December 2023), the first reaction was, "Say what?" It turns out that the Hypercomputer is Google's t Read more…

AMD MI3000A

How AMD May Get Across the CUDA Moat

October 5, 2023

When discussing GenAI, the term "GPU" almost always enters the conversation and the topic often moves toward performance and access. Interestingly, the word "GPU" is assumed to mean "Nvidia" products. (As an aside, the popular Nvidia hardware used in GenAI are not technically... Read more…

Shutterstock 1606064203

Meta’s Zuckerberg Puts Its AI Future in the Hands of 600,000 GPUs

January 25, 2024

In under two minutes, Meta's CEO, Mark Zuckerberg, laid out the company's AI plans, which included a plan to build an artificial intelligence system with the eq Read more…

Google Introduces ‘Hypercomputer’ to Its AI Infrastructure

December 11, 2023

Google ran out of monikers to describe its new AI system released on December 7. Supercomputer perhaps wasn't an apt description, so it settled on Hypercomputer Read more…

China Is All In on a RISC-V Future

January 8, 2024

The state of RISC-V in China was discussed in a recent report released by the Jamestown Foundation, a Washington, D.C.-based think tank. The report, entitled "E Read more…

Intel Won’t Have a Xeon Max Chip with New Emerald Rapids CPU

December 14, 2023

As expected, Intel officially announced its 5th generation Xeon server chips codenamed Emerald Rapids at an event in New York City, where the focus was really o Read more…

IBM Quantum Summit: Two New QPUs, Upgraded Qiskit, 10-year Roadmap and More

December 4, 2023

IBM kicks off its annual Quantum Summit today and will announce a broad range of advances including its much-anticipated 1121-qubit Condor QPU, a smaller 133-qu Read more…

  • arrow
  • Click Here for More Headlines
  • arrow
HPCwire